These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33788898)

  • 1. Predictors of shortages of opioid analgesics in the US: Are the characteristics of the drug company the missing puzzle piece?
    Rodriguez-Monguio R; Naveed M; Seoane-Vazquez E
    PLoS One; 2021; 16(3):e0249274. PubMed ID: 33788898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. US Generic Antiseizure Medication Supply Chain: Observations from Analysis of US Government Databases.
    Javarayee P; Meylor J; Shahrukh S; Pollock S; Andrade-Machado R; Sah J; Patel H
    Seizure; 2024 Apr; 117():83-89. PubMed ID: 38354597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic and technological drivers of generic sterile injectable drug shortages.
    Woodcock J; Wosinska M
    Clin Pharmacol Ther; 2013 Feb; 93(2):170-6. PubMed ID: 23337525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with drug shortages in Canada: a retrospective cohort study.
    Zhang W; Guh DP; Sun H; Lynd LD; Hollis A; Grootendorst P; Anis AH
    CMAJ Open; 2020; 8(3):E535-E544. PubMed ID: 32873582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The US Opioid Crisis: Current Federal and State Legal Issues.
    Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK
    Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Drug Shortages and Association with Generic Drug Prices: A Retrospective Cohort Study.
    Dave CV; Pawar A; Fox ER; Brill G; Kesselheim AS
    Value Health; 2018 Nov; 21(11):1286-1290. PubMed ID: 30442275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a predictive model to predict and manage drug shortages.
    Liu I; Colmenares E; Tak C; Vest MH; Clark H; Oertel M; Pappas A
    Am J Health Syst Pharm; 2021 Jul; 78(14):1309-1316. PubMed ID: 33821926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Acute Postoperative Pain Management During an Injectable Opioid Shortage.
    Tran KK; VanDaele MA; Tran S; Stevens SA; Maltese Dietrich N; Franck AJ
    Ann Pharmacother; 2021 May; 55(5):611-617. PubMed ID: 32959671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affordability and availability of off-patent drugs in the United States-the case for importing from abroad: observational study.
    Gupta R; Bollyky TJ; Cohen M; Ross JS; Kesselheim AS
    BMJ; 2018 Mar; 360():k831. PubMed ID: 29555641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shortage of generic neurologic therapeutics: An escalating threat to patient care.
    Omorodion JO; Algahtani RM; Zocchi MS; Fox ER; Pines JM; Kaminski HJ
    Neurology; 2017 Dec; 89(24):2431-2437. PubMed ID: 29142086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Projections for antiinfective drug shortages and time to actual resolution.
    McLaughlin MM; Pentoney Z; Skoglund E; Scheetz MH
    Am J Health Syst Pharm; 2014 Dec; 71(23):2074-8. PubMed ID: 25404600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How the US Food and Drug Administration can solve the prescription drug shortage problem.
    Schweitzer SO
    Am J Public Health; 2013 May; 103(5):e10-4. PubMed ID: 23488502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical drug shortages: implications for emergency medicine.
    Mazer-Amirshahi M; Pourmand A; Singer S; Pines JM; van den Anker J
    Acad Emerg Med; 2014 Jun; 21(6):704-11. PubMed ID: 25039558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selegiline shortage: Causes and costs of a generic drug shortage.
    Dorsey ER; Thompson JP; Dayoub EJ; George B; Saubermann LA; Holloway RG
    Neurology; 2009 Jul; 73(3):213-7. PubMed ID: 19620609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interchangeability, Safety and Efficacy of Modified-Release Drug Formulations in the USA: The Case of Opioid and Other Nervous System Drugs.
    Seoane-Vazquez E; Rodriguez-Monguio R; Hansen R
    Clin Drug Investig; 2016 Apr; 36(4):281-92. PubMed ID: 26818406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug shortages: Implications for medical toxicology.
    Mazer-Amirshahi M; Hawley KL; Zocchi M; Fox E; Pines JM; Nelson LS
    Clin Toxicol (Phila); 2015 Jul; 53(6):519-24. PubMed ID: 25951876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland.
    Heiskanen K; Ahonen R; Kanerva R; Karttunen P; Timonen J
    PLoS One; 2017; 12(6):e0179479. PubMed ID: 28658307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The French reporting system for drug shortages: description and trends from 2012 to 2018: an observational retrospective study.
    Benhabib A; Ioughlissen S; Ratignier-Carbonneil C; Maison P
    BMJ Open; 2020 Mar; 10(3):e034033. PubMed ID: 32139487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Call to action: finding solutions for the drug shortage crisis in the United States.
    Fox ER; Tyler LS
    Clin Pharmacol Ther; 2013 Feb; 93(2):145-7. PubMed ID: 23337524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zohydro approval by food and drug administration: controversial or frightening?
    Manchikanti L; Atluri S; Candido KD; Boswell MV; Simopoulos TT; Grider JS; Falco FJ; Hirsch JA
    Pain Physician; 2014; 17(4):E437-50. PubMed ID: 25054396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.